ACDEs treatment decreased the phosphorylation of pathway components in the liver tissue of NAFLD mice, significantly inhibiting the excessive activation of the NF-κB pathway induced by MCD stimulation (Figure 5D). Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.